|
|
|
| Effects of remazolam besylate and propofol on the anesthesia effect and the recovery time of patients undergone hysteroscopic surgery |
| The Second People's Hospital of Lanzhou, Lanzhou, Gansu Province, 730000 |
|
|
|
|
Abstract To explore the effects of remazolam besylate and propofol on the anesthesia effect and the recovery time of patients undergone hysteroscopic surgery. Methods: A total of 80 patients who wanted hysteroscopic surgery were selected and randomly divided into study group and control group (40 cases in each group) according to the random number table from August 2019 to December 2020. The patients in the control group were given propofol anesthesia, and the patients in the study group were given remazolam besylate anesthesia. The changes of vital signs before surgery, during surgery, and after surgery, the anesthesia effect, the postoperative pain situation by visual analog scale (VAS), and the postoperative adverse reactions rate of the patients were compared between the two groups. Results: The values of heart rate (HR), blood oxygen saturation (SPO2), systolic blood pressure (SBP), and diastolic blood pressure (DBP) of the patients in the study group during and after surgery had no significant different from those of the patients before surgery (P>0.05), while which of the patients in the control group had significant different from those before surgery (P<0.05). The onset time (2.2±0.5 min), the recovery time of orientation (5.5±1.5 min), and the recovery time (3.2±1.1 min) of anesthesia of the patients in the study group were significantly shorter than those (2.9±0.9 min, 6.7±2.1 min, and 4.8±1.4 min) of the patients in the control group. The postoperative VAS score (2.6±0.8) of the patients in the study group was significantly lower than that (5.3±1.2) of the patients in the control group, and the incidence of total adverse reactions (7.5%) of the patients in the study group was significantly lower than that (32.5%) of the patients in the control group (P<0.05). Conclusion: Remazolam besylate used in hysteroscopic surgery can improve intraoperative vital signs more stable, promote anesthetic effect and postoperative recovery, relieve postoperative pain, and reduce adverse reactions.
|
|
|
|
|
|
|
|
|
